These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 10612355)
21. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs. White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726 [TBL] [Abstract][Full Text] [Related]
22. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. Smith SE; Parvez NS; Chapman AG; Meldrum BS Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333 [TBL] [Abstract][Full Text] [Related]
23. Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels. Cleton A; Altorf BA; Voskuyl RA; Danhof M Br J Pharmacol; 2000 Jul; 130(5):1037-44. PubMed ID: 10882388 [TBL] [Abstract][Full Text] [Related]
24. Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia. Sundman-Eriksson I; Blennow K; Davidsson P; Dandenell AK; Marcusson J Neuropsychobiology; 2002; 45(1):7-11. PubMed ID: 11803235 [TBL] [Abstract][Full Text] [Related]
25. In vivo labeling of the central GABA uptake carrier with 3H-Tiagabine. Suzdak PD; Swedberg MD; Andersen KE; Knutsen LJ; Braestrup C Life Sci; 1992; 51(24):1857-68. PubMed ID: 1333027 [TBL] [Abstract][Full Text] [Related]
26. Actions of nipecotic acid and SKF89976A on GABA transporter in cone-driven horizontal cells dissociated from the catfish retina. Takahashi K; Miyoshi S; Kaneko A; Copenhagen DR Jpn J Physiol; 1995; 45(3):457-73. PubMed ID: 7474528 [TBL] [Abstract][Full Text] [Related]
27. Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol. Madsen KK; Ebert B; Clausen RP; Krogsgaard-Larsen P; Schousboe A; White HS J Pharmacol Exp Ther; 2011 Jul; 338(1):214-9. PubMed ID: 21450931 [TBL] [Abstract][Full Text] [Related]
29. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Coenen AM; Blezer EH; van Luijtelaar EL Epilepsy Res; 1995 Jun; 21(2):89-94. PubMed ID: 7588592 [TBL] [Abstract][Full Text] [Related]
30. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures. Ueda Y; Doi T; Tokumaru J; Willmore LJ Brain Res Mol Brain Res; 2003 Aug; 116(1-2):1-6. PubMed ID: 12941455 [TBL] [Abstract][Full Text] [Related]
31. Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze. Schmitt U; Hiemke C Behav Brain Res; 2002 Jul; 133(2):391-4. PubMed ID: 12110474 [TBL] [Abstract][Full Text] [Related]
32. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Adkins JC; Noble S Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548 [TBL] [Abstract][Full Text] [Related]
33. Comparative study of the anticonvulsant effect of gamma-aminobutyric acid agonists in the feline kindling model of epilepsy. Morimoto K; Sanei T; Sato K Epilepsia; 1993; 34(6):1123-9. PubMed ID: 8243367 [TBL] [Abstract][Full Text] [Related]
34. Time-dependent and regional expression of GABA transporter mRNAs following amygdala-kindled seizures in rats. Hirao T; Morimoto K; Yamamoto Y; Watanabe T; Sato H; Sato K; Sato S; Yamada N; Tanaka K; Suwaki H Brain Res Mol Brain Res; 1998 Feb; 54(1):49-55. PubMed ID: 9526043 [TBL] [Abstract][Full Text] [Related]
35. Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats. McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH Psychopharmacology (Berl); 2008 May; 197(4):591-600. PubMed ID: 18264695 [TBL] [Abstract][Full Text] [Related]
36. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs. Madsen KK; Clausen RP; Larsson OM; Krogsgaard-Larsen P; Schousboe A; White HS J Neurochem; 2009 May; 109 Suppl 1():139-44. PubMed ID: 19393020 [TBL] [Abstract][Full Text] [Related]
37. [(3)H]Tiagabine binding to GABA transporter-1 (GAT-1) in suicidal depression. Sundman-Eriksson I; Allard P J Affect Disord; 2002 Sep; 71(1-3):29-33. PubMed ID: 12167498 [TBL] [Abstract][Full Text] [Related]
38. The inhibitory neural circuitry as target of antiepileptic drugs. Böhme I; Lüddens H Curr Med Chem; 2001 Sep; 8(11):1257-74. PubMed ID: 11562265 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs. Eckstein-Ludwig U; Fei J; Schwarz W Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839 [TBL] [Abstract][Full Text] [Related]
40. Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression. Sałat K; Podkowa A; Kowalczyk P; Kulig K; Dziubina A; Filipek B; Librowski T Pharmacol Rep; 2015 Jun; 67(3):465-72. PubMed ID: 25933955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]